Medtronic (MDT) got the FDA to approve its new drug-coated stent called the Endeavor. The agency did have some concerns about whether the product has long-term risks or whether it is more…
According to Reuters, several retailers cut holiday forecasts and the economy slows. Reuters writes that Chrysler has reached an accord with the UAW. Reuters reports that Boeing (BA) has delayed delivery of…
Medtronic (MDT) has decided to get into the stent business, making the little mesh tubes that keep arteries open. It is a perverse selection because Boston Scientific (BSX) and Johnson & Johnson…
Medtronic (NYSE:MDT) posts earnings after the close on Tuesday, August 21, and First Call estimates are $0.62 EPS on $3.17 Billion in revenues. The following quarter is looking like estimates are $0.65…
Douglas A. McIntyre (ADTN) Adtran $0.28 EPS versus $0.28 estimate.(AIZ) Assurant CEO and CFO received SEC WELLS NOTICE.(ASD) American Standard noted as a positive ahead of split-up by Cramer on MAD MONEY.(CVO) Cenveo is acquiring…
As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a bit of a mixed bag. GlaxoSmithkline (GSK) saw the lagest increase, but…
Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw an increased activity in short selling in May versus April. Below is…
Medtronic (MDT-NYSE) posted quarterly results with revenues up 75 to $3.28 Billion, helped on currency by $71 million. Net earnings were 4812 million, or $0.70 EPS but $0.66 adjusting for charges and…
Douglas A. McIntyre